Abstract
Immunotherapy has proven activity in several types of cancer; however, the mechanisms of action of immunotherapy can cause several different immune-related toxicities. Advanced practitioners are in a unique position to recognize the timing and manage these toxicities to help patients realize the maximal clinical efficacy of their therapy.
